Creo Medical Limited (CREO.L) LSE

Currency In GBp

AD

Creo Medical Limited

Address

Unit 2, Creo House

Chepstow, WA NP16 5UH

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 1291 606005

Sector

Healthcare

Industry

Medical - Devices

Employees

278

First IPO Date

December 09, 2016

Key Executives

NameTitlePayYear Born
Craig Jonathan GullifordChief Executive Officer & Executive Director502,5371970
Christopher Paul HancockFounder & CTO127,2691967
David Gerard WoodsChief Commercial Officer152,8351965
Richard John ReesChief Financial Officer & Executive Director350,4111976
Richard Gary CravenSecretary0N/A
Phil HalesSales & Marketing Director0N/A
AD

Description

Creo Medical Limited, a UK-based enterprise and subsidiary of Creo Medical Group plc, specializes in the innovation and creation of electrosurgical medical devices for surgical endoscopy applications. Founded in 2003 as MicroOncology Ltd and headquartered in Chepstow, the company's core offering is Croma, an advanced energy platform. This platform is engineered to power a diverse collection of multi-modal instruments, thereby enhancing therapeutic interventions for both medical professionals and patients. Its extensive product portfolio includes specialized tools such as Speedboat Inject, an adaptable energy instrument designed for flexible endoscopic procedures; Speedboat Slim, a flexible bipolar radiofrequency (RF) and microwave device for precise tissue cutting and coagulation; MicroBlate Fine, a microwave needle for ablation; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device engineered to control upper and lower gastrointestinal bleeds; and SpydrBlade Flex, a flexible scissor-like instrument that integrates bipolar RF and microwave technology to grasp, cut, and coagulate highly vascularized tissues.

AD